TP53 and neoplasm: A pilot study conducted by van Ginkel et al. [14] detected TP53 mutations by ddPCR analysis in all six plasma cfDNA samples from HNSCC patients, in concordance with the TP53 mutations previously detected by NGS in primary tumor samples.